Rank | Gene Set | Z-score |
---|---|---|
1 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 8.67762163 |
2 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 8.67762163 |
3 | neutrophil mediated immunity (GO:0002446) | 8.08588171 |
4 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 8.07175397 |
5 | regulation of MHC class II biosynthetic process (GO:0045346) | 7.03872384 |
6 | negative regulation of growth of symbiont in host (GO:0044130) | 7.03808763 |
7 | negative regulation of growth of symbiont involved in interaction with host (GO:0044146) | 7.03808763 |
8 | modulation of growth of symbiont involved in interaction with host (GO:0044144) | 7.03808763 |
9 | regulation of growth of symbiont in host (GO:0044126) | 7.03808763 |
10 | microglial cell activation (GO:0001774) | 6.92036961 |
11 | myeloid leukocyte mediated immunity (GO:0002444) | 6.62066509 |
12 | disruption of cells of other organism (GO:0044364) | 6.57022955 |
13 | killing of cells of other organism (GO:0031640) | 6.57022955 |
14 | positive regulation of chemokine biosynthetic process (GO:0045080) | 6.54597550 |
15 | defense response to fungus (GO:0050832) | 6.39380945 |
16 | response to fungus (GO:0009620) | 6.11573083 |
17 | protoporphyrinogen IX biosynthetic process (GO:0006782) | 6.08191063 |
18 | purine deoxyribonucleotide catabolic process (GO:0009155) | 5.74490929 |
19 | DNA deamination (GO:0045006) | 5.74485015 |
20 | ribosomal small subunit assembly (GO:0000028) | 5.74271029 |
21 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 5.46622269 |
22 | protoporphyrinogen IX metabolic process (GO:0046501) | 5.27483981 |
23 | removal of superoxide radicals (GO:0019430) | 5.20345327 |
24 | cellular response to superoxide (GO:0071451) | 5.20345327 |
25 | cellular response to oxygen radical (GO:0071450) | 5.20345327 |
26 | macrophage chemotaxis (GO:0048246) | 4.91648908 |
27 | cellular response to zinc ion (GO:0071294) | 4.81315574 |
28 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 4.75713617 |
29 | glial cell migration (GO:0008347) | 4.75224523 |
30 | leukocyte mediated cytotoxicity (GO:0001909) | 4.72736991 |
31 | telomere maintenance via semi-conservative replication (GO:0032201) | 4.59980717 |
32 | DNA strand elongation involved in DNA replication (GO:0006271) | 4.59483031 |
33 | respiratory burst (GO:0045730) | 4.51019358 |
34 | induction of positive chemotaxis (GO:0050930) | 4.50744714 |
35 | DNA strand elongation (GO:0022616) | 4.40620470 |
36 | reactive oxygen species biosynthetic process (GO:1903409) | 4.38556059 |
37 | response to superoxide (GO:0000303) | 4.23830142 |
38 | deoxyribonucleotide catabolic process (GO:0009264) | 4.21990909 |
39 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 4.21194328 |
40 | response to oxygen radical (GO:0000305) | 4.20900811 |
41 | pentose-phosphate shunt (GO:0006098) | 4.15581436 |
42 | viral transcription (GO:0019083) | 4.14059250 |
43 | cotranslational protein targeting to membrane (GO:0006613) | 4.11606795 |
44 | protein targeting to ER (GO:0045047) | 4.09188686 |
45 | deoxyribose phosphate catabolic process (GO:0046386) | 4.08970861 |
46 | base-excision repair, AP site formation (GO:0006285) | 4.04146436 |
47 | heme biosynthetic process (GO:0006783) | 4.03330132 |
48 | translational termination (GO:0006415) | 4.02275802 |
49 | cell wall macromolecule catabolic process (GO:0016998) | 3.99866026 |
50 | centriole replication (GO:0007099) | 3.93489831 |
51 | protein localization to endoplasmic reticulum (GO:0070972) | 3.91301447 |
52 | DNA replication initiation (GO:0006270) | 3.91014374 |
53 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 3.89141326 |
54 | telomere maintenance via recombination (GO:0000722) | 3.87990807 |
55 | NADPH regeneration (GO:0006740) | 3.84339541 |
56 | purine deoxyribonucleotide metabolic process (GO:0009151) | 3.83744797 |
57 | macrophage activation (GO:0042116) | 3.76812253 |
58 | translational elongation (GO:0006414) | 3.62146260 |
59 | DNA unwinding involved in DNA replication (GO:0006268) | 3.62119472 |
60 | IMP metabolic process (GO:0046040) | 3.48673500 |
61 | glucose 6-phosphate metabolic process (GO:0051156) | 3.48602532 |
62 | mitotic recombination (GO:0006312) | 3.47234020 |
63 | pentose metabolic process (GO:0019321) | 3.47002655 |
64 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.46964611 |
65 | ribosomal small subunit biogenesis (GO:0042274) | 3.46359841 |
66 | angiotensin maturation (GO:0002003) | 3.44639146 |
67 | innate immune response in mucosa (GO:0002227) | 3.43155598 |
68 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.42330820 |
69 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.42330820 |
70 | cell killing (GO:0001906) | 3.38123812 |
71 | response to food (GO:0032094) | 3.35680097 |
72 | inflammatory response to antigenic stimulus (GO:0002437) | 3.32755337 |
73 | cell wall macromolecule metabolic process (GO:0044036) | 3.30853705 |
74 | DNA replication checkpoint (GO:0000076) | 3.28772714 |
75 | porphyrin-containing compound biosynthetic process (GO:0006779) | 3.28367419 |
76 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 3.28104831 |
77 | telomere maintenance via telomere lengthening (GO:0010833) | 3.26498621 |
78 | hydrogen peroxide metabolic process (GO:0042743) | 3.22351279 |
79 | positive regulation of interleukin-1 beta production (GO:0032731) | 3.21553332 |
80 | maturation of SSU-rRNA (GO:0030490) | 3.19478260 |
81 | regulation of chemokine biosynthetic process (GO:0045073) | 3.18644103 |
82 | negative regulation of chemokine production (GO:0032682) | 3.17906968 |
83 | neutrophil activation involved in immune response (GO:0002283) | 3.16527388 |
84 | protein localization to kinetochore (GO:0034501) | 3.14172895 |
85 | cellular protein complex disassembly (GO:0043624) | 3.10570996 |
86 | nucleobase biosynthetic process (GO:0046112) | 3.10496416 |
87 | translational initiation (GO:0006413) | 3.07882305 |
88 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 3.07830234 |
89 | interaction with symbiont (GO:0051702) | 3.07465277 |
90 | macrophage differentiation (GO:0030225) | 3.06547783 |
91 | angiogenesis involved in wound healing (GO:0060055) | 3.06224253 |
92 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 3.04774911 |
93 | antibacterial humoral response (GO:0019731) | 3.02830223 |
94 | hydrogen peroxide catabolic process (GO:0042744) | 3.01835503 |
95 | leukotriene biosynthetic process (GO:0019370) | 3.01749927 |
96 | viral life cycle (GO:0019058) | 2.98693636 |
97 | IMP biosynthetic process (GO:0006188) | 2.96974376 |
98 | GDP-mannose metabolic process (GO:0019673) | 2.96244149 |
99 | 2-deoxyribonucleotide metabolic process (GO:0009394) | 2.96108832 |
100 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.94651510 |
101 | tetrapyrrole biosynthetic process (GO:0033014) | 2.92356380 |
102 | pseudouridine synthesis (GO:0001522) | 2.91246820 |
103 | nucleotide-excision repair, DNA gap filling (GO:0006297) | 2.90362500 |
104 | signal peptide processing (GO:0006465) | 2.90345917 |
105 | negative regulation of B cell apoptotic process (GO:0002903) | 2.90315690 |
106 | heme metabolic process (GO:0042168) | 2.90235979 |
107 | centriole assembly (GO:0098534) | 2.89931655 |
108 | positive regulation of interleukin-1 production (GO:0032732) | 2.89055313 |
109 | low-density lipoprotein particle remodeling (GO:0034374) | 2.87765821 |
110 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 2.87582022 |
111 | positive regulation of phagocytosis (GO:0050766) | 2.82988996 |
112 | glucose catabolic process (GO:0006007) | 2.82946512 |
113 | deoxyribose phosphate metabolic process (GO:0019692) | 2.82225318 |
114 | protein complex disassembly (GO:0043241) | 2.75315201 |
115 | regulation of chemokine production (GO:0032642) | 2.74717232 |
116 | positive regulation of histone H3-K4 methylation (GO:0051571) | 2.74701898 |
117 | antimicrobial humoral response (GO:0019730) | 2.72289707 |
118 | modification by host of symbiont morphology or physiology (GO:0051851) | 2.71773563 |
119 | mannosylation (GO:0097502) | 2.71391554 |
120 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.71099118 |
121 | nucleobase-containing small molecule interconversion (GO:0015949) | 2.70984669 |
122 | negative regulation of granulocyte differentiation (GO:0030853) | 2.70656123 |
123 | necroptotic process (GO:0070266) | 2.69044810 |
124 | CENP-A containing nucleosome assembly (GO:0034080) | 2.68511362 |
125 | positive regulation of histone deacetylation (GO:0031065) | 2.68343927 |
126 | superoxide metabolic process (GO:0006801) | 2.68282744 |
127 | protein localization to chromosome, centromeric region (GO:0071459) | 2.67914937 |
128 | response to peptidoglycan (GO:0032494) | 2.66941224 |
129 | protein targeting to membrane (GO:0006612) | 2.66668786 |
130 | defense response to Gram-negative bacterium (GO:0050829) | 2.65591085 |
131 | translation (GO:0006412) | 2.65019949 |
132 | leukotriene metabolic process (GO:0006691) | 2.64643697 |
133 | mucosal immune response (GO:0002385) | 2.64612215 |
134 | autophagic vacuole fusion (GO:0000046) | 2.62930133 |
135 | ribosome assembly (GO:0042255) | 2.61583164 |
136 | pyrimidine nucleotide catabolic process (GO:0006244) | 2.60937998 |
137 | positive regulation of cytokine biosynthetic process (GO:0042108) | 2.60807361 |
138 | regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083) | 2.60431848 |
139 | response to interferon-beta (GO:0035456) | 2.58910154 |
140 | chromatin remodeling at centromere (GO:0031055) | 2.57204742 |
141 | L-fucose catabolic process (GO:0042355) | 2.56821382 |
142 | fucose catabolic process (GO:0019317) | 2.56821382 |
143 | L-fucose metabolic process (GO:0042354) | 2.56821382 |
144 | macromolecular complex disassembly (GO:0032984) | 2.56774225 |
145 | organ or tissue specific immune response (GO:0002251) | 2.55741103 |
146 | purine nucleobase biosynthetic process (GO:0009113) | 2.55665942 |
147 | positive regulation of B cell differentiation (GO:0045579) | 2.54771599 |
148 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 2.53606451 |
149 | negative regulation of interleukin-8 production (GO:0032717) | 2.53210696 |
150 | translesion synthesis (GO:0019985) | 2.52878683 |
151 | deoxyribonucleoside triphosphate metabolic process (GO:0009200) | 2.52219359 |
152 | formation of translation preinitiation complex (GO:0001731) | 2.50767835 |
153 | intra-S DNA damage checkpoint (GO:0031573) | 2.50505982 |
154 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 2.50169940 |
155 | cellular response to exogenous dsRNA (GO:0071360) | 2.50140059 |
156 | mast cell activation (GO:0045576) | 2.49359295 |
157 | plasma lipoprotein particle remodeling (GO:0034369) | 2.47667962 |
158 | protein-lipid complex remodeling (GO:0034368) | 2.47667962 |
159 | macromolecular complex remodeling (GO:0034367) | 2.47667962 |
160 | cellular extravasation (GO:0045123) | 11.3045597 |
Rank | Gene Set | Z-score |
---|---|---|
1 | E2F7_22180533_ChIP-Seq_HELA_Human | 7.61829332 |
2 | * EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 3.92107306 |
3 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 3.30263059 |
4 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 3.29707369 |
5 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.94392123 |
6 | * VDR_21846776_ChIP-Seq_THP-1_Human | 2.82638877 |
7 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.79394565 |
8 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.77314937 |
9 | * SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.72079357 |
10 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.68684878 |
11 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 2.63889377 |
12 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.50789005 |
13 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.49760309 |
14 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.43263903 |
15 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.41694466 |
16 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.39213046 |
17 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.38186483 |
18 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.36700941 |
19 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.35509936 |
20 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 2.33213559 |
21 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.27597070 |
22 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.19666610 |
23 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.17351812 |
24 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 2.16781507 |
25 | * FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 2.15131312 |
26 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 2.15019982 |
27 | MYC_22102868_ChIP-Seq_BL_Human | 2.13943485 |
28 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.12331630 |
29 | * SPI1_23547873_ChIP-Seq_NB4_Human | 2.09090638 |
30 | * RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.06814771 |
31 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.01655471 |
32 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.94245616 |
33 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.92442086 |
34 | * SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.92012663 |
35 | * VDR_24763502_ChIP-Seq_THP-1_Human | 1.91415170 |
36 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.89133436 |
37 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.88166053 |
38 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.87644402 |
39 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.87451459 |
40 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.85685832 |
41 | * ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.84754706 |
42 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.84426939 |
43 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.79232538 |
44 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.74509503 |
45 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.73724734 |
46 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.73298359 |
47 | GATA1_22025678_ChIP-Seq_K562_Human | 1.73193256 |
48 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.73172791 |
49 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.68055013 |
50 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.65332201 |
51 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.63092595 |
52 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.61338425 |
53 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.58943233 |
54 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.58638631 |
55 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.57423477 |
56 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.56290099 |
57 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.56207128 |
58 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.55179598 |
59 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.54378206 |
60 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.52839402 |
61 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.50898085 |
62 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.49745051 |
63 | * BCL6_27268052_Chip-Seq_Bcells_Human | 1.48375860 |
64 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.47823252 |
65 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.47790754 |
66 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.45989680 |
67 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.43525751 |
68 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.42361353 |
69 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.40671015 |
70 | * MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.40311712 |
71 | * GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.39195788 |
72 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.39054349 |
73 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.37960292 |
74 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.37523254 |
75 | MYB_26560356_Chip-Seq_TH2_Human | 1.35829931 |
76 | * EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.33524059 |
77 | P68_20966046_ChIP-Seq_HELA_Human | 1.33471029 |
78 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.33177014 |
79 | * STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.32750318 |
80 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.30673019 |
81 | MAF_26560356_Chip-Seq_TH2_Human | 1.29286240 |
82 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.28484405 |
83 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.28127861 |
84 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.27304369 |
85 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.27137287 |
86 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.23629200 |
87 | UTX_26944678_Chip-Seq_JUKART_Human | 1.23416958 |
88 | MAF_26560356_Chip-Seq_TH1_Human | 1.21946663 |
89 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.21640526 |
90 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.21576896 |
91 | * TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.21425220 |
92 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.20778451 |
93 | MYB_26560356_Chip-Seq_TH1_Human | 1.20566154 |
94 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.19055425 |
95 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.17661748 |
96 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.15000995 |
97 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 1.13616022 |
98 | P300_27268052_Chip-Seq_Bcells_Human | 1.12616977 |
99 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.12051637 |
100 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.11428116 |
101 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.11188886 |
102 | SPI1_20517297_ChIP-Seq_HL60_Human | 1.10899642 |
103 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.10345159 |
104 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.09301951 |
105 | PHF8_20622854_ChIP-Seq_HELA_Human | 1.09041197 |
106 | * GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.09025243 |
107 | * E2F1_20622854_ChIP-Seq_HELA_Human | 1.08584726 |
108 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.07585367 |
109 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.07131358 |
110 | SPI1_23127762_ChIP-Seq_K562_Human | 1.07102203 |
111 | * CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.05887526 |
112 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.05769446 |
113 | RAC3_21632823_ChIP-Seq_H3396_Human | 1.05273091 |
114 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 1.04926893 |
115 | FOXP1_21924763_ChIP-Seq_HESCs_Human | 1.04827509 |
116 | * SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.04461105 |
117 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.04287005 |
118 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 1.03802744 |
119 | * YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.03599726 |
120 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.03426339 |
121 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.02102536 |
122 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 1.01637835 |
123 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.01536142 |
124 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.00505705 |
125 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.00098555 |
126 | KDM5A_27292631_Chip-Seq_BREAST_Human | 0.97747889 |
127 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.96795991 |
128 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 0.95690581 |
129 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.94860836 |
130 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.94238418 |
131 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.93359202 |
132 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.92570642 |
133 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.91923223 |
134 | * PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.90707737 |
135 | * PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.90370058 |
136 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.89611944 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0005083_abnormal_biliary_tract | 4.77838186 |
2 | MP0002396_abnormal_hematopoietic_system | 4.35255984 |
3 | MP0003693_abnormal_embryo_hatching | 3.58676590 |
4 | MP0005174_abnormal_tail_pigmentation | 2.98214109 |
5 | MP0003303_peritoneal_inflammation | 2.92028502 |
6 | MP0003436_decreased_susceptibility_to | 2.86991441 |
7 | MP0001835_abnormal_antigen_presentation | 2.77690269 |
8 | MP0010094_abnormal_chromosome_stability | 2.77084947 |
9 | MP0009785_altered_susceptibility_to | 2.76266540 |
10 | MP0005670_abnormal_white_adipose | 2.68151423 |
11 | MP0003172_abnormal_lysosome_physiology | 2.61905088 |
12 | * MP0002419_abnormal_innate_immunity | 2.58906806 |
13 | MP0008057_abnormal_DNA_replication | 2.55570423 |
14 | MP0003183_abnormal_peptide_metabolism | 2.55188522 |
15 | MP0003724_increased_susceptibility_to | 2.53389288 |
16 | MP0005025_abnormal_response_to | 2.49594309 |
17 | MP0005464_abnormal_platelet_physiology | 2.45484422 |
18 | MP0000490_abnormal_crypts_of | 2.45169109 |
19 | MP0000465_gastrointestinal_hemorrhage | 2.44412334 |
20 | MP0005075_abnormal_melanosome_morpholog | 2.38578314 |
21 | MP0002166_altered_tumor_susceptibility | 2.37268596 |
22 | MP0003111_abnormal_nucleus_morphology | 2.30674023 |
23 | MP0005360_urolithiasis | 2.23350425 |
24 | MP0004957_abnormal_blastocyst_morpholog | 2.19502712 |
25 | MP0000569_abnormal_digit_pigmentation | 2.16222138 |
26 | MP0002148_abnormal_hypersensitivity_rea | 2.14388842 |
27 | MP0009379_abnormal_foot_pigmentation | 2.13207814 |
28 | MP0008961_abnormal_basal_metabolism | 2.13095200 |
29 | MP0004808_abnormal_hematopoietic_stem | 2.12559247 |
30 | MP0003077_abnormal_cell_cycle | 2.12336166 |
31 | MP0001545_abnormal_hematopoietic_system | 2.01391532 |
32 | MP0005397_hematopoietic_system_phenotyp | 2.01391532 |
33 | MP0008058_abnormal_DNA_repair | 1.96102891 |
34 | * MP0002420_abnormal_adaptive_immunity | 1.94440743 |
35 | MP0005000_abnormal_immune_tolerance | 1.91272906 |
36 | MP0002398_abnormal_bone_marrow | 1.90044592 |
37 | * MP0001819_abnormal_immune_cell | 1.89616276 |
38 | MP0001853_heart_inflammation | 1.87207091 |
39 | MP0002006_tumorigenesis | 1.80898034 |
40 | MP0000015_abnormal_ear_pigmentation | 1.77214674 |
41 | MP0000716_abnormal_immune_system | 1.77124580 |
42 | MP0002095_abnormal_skin_pigmentation | 1.74921408 |
43 | MP0009333_abnormal_splenocyte_physiolog | 1.74848096 |
44 | MP0003806_abnormal_nucleotide_metabolis | 1.72010522 |
45 | MP0005671_abnormal_response_to | 1.69769093 |
46 | MP0002452_abnormal_antigen_presenting | 1.68492204 |
47 | MP0000858_altered_metastatic_potential | 1.68402128 |
48 | MP0002723_abnormal_immune_serum | 1.65323882 |
49 | MP0002429_abnormal_blood_cell | 1.64958158 |
50 | MP0010307_abnormal_tumor_latency | 1.64601928 |
51 | MP0002722_abnormal_immune_system | 1.64128889 |
52 | MP0001986_abnormal_taste_sensitivity | 1.62095450 |
53 | MP0000689_abnormal_spleen_morphology | 1.60905185 |
54 | MP0003763_abnormal_thymus_physiology | 1.60426879 |
55 | MP0001800_abnormal_humoral_immune | 1.58353578 |
56 | MP0000685_abnormal_immune_system | 1.57584534 |
57 | MP0003252_abnormal_bile_duct | 1.54930694 |
58 | MP0004742_abnormal_vestibular_system | 1.54761021 |
59 | MP0001845_abnormal_inflammatory_respons | 1.52510639 |
60 | MP0002160_abnormal_reproductive_system | 1.52061016 |
61 | MP0010155_abnormal_intestine_physiology | 1.48110790 |
62 | MP0004043_abnormal_pH_regulation | 1.46580458 |
63 | MP0006054_spinal_hemorrhage | 1.46544675 |
64 | MP0002019_abnormal_tumor_incidence | 1.44019927 |
65 | MP0008007_abnormal_cellular_replicative | 1.43889022 |
66 | MP0002405_respiratory_system_inflammati | 1.41869357 |
67 | MP0001873_stomach_inflammation | 1.41367498 |
68 | MP0003866_abnormal_defecation | 1.38694063 |
69 | MP0001533_abnormal_skeleton_physiology | 1.35037722 |
70 | MP0004185_abnormal_adipocyte_glucose | 1.29762548 |
71 | MP0003186_abnormal_redox_activity | 1.29130566 |
72 | MP0005666_abnormal_adipose_tissue | 1.28504622 |
73 | MP0008995_early_reproductive_senescence | 1.28414940 |
74 | MP0000343_altered_response_to | 1.27602129 |
75 | MP0001663_abnormal_digestive_system | 1.20697095 |
76 | MP0005220_abnormal_exocrine_pancreas | 1.20529670 |
77 | MP0006036_abnormal_mitochondrial_physio | 1.18648063 |
78 | MP0000703_abnormal_thymus_morphology | 1.18607197 |
79 | MP0005058_abnormal_lysosome_morphology | 1.18113093 |
80 | MP0003123_paternal_imprinting | 1.15269178 |
81 | MP0005076_abnormal_cell_differentiation | 1.12535025 |
82 | MP0003656_abnormal_erythrocyte_physiolo | 1.11409457 |
83 | MP0005365_abnormal_bile_salt | 1.10246776 |
84 | MP0008469_abnormal_protein_level | 1.09546884 |
85 | MP0003221_abnormal_cardiomyocyte_apopto | 1.08624462 |
86 | MP0005451_abnormal_body_composition | 1.08138418 |
87 | MP0001764_abnormal_homeostasis | 1.04239689 |
88 | MP0005085_abnormal_gallbladder_physiolo | 1.02851395 |
89 | MP0005375_adipose_tissue_phenotype | 1.02775819 |
90 | MP0000313_abnormal_cell_death | 1.02612144 |
91 | MP0003786_premature_aging | 1.02568110 |
92 | MP0005334_abnormal_fat_pad | 1.01962088 |
93 | MP0005409_darkened_coat_color | 0.98617553 |
94 | MP0001851_eye_inflammation | 0.98234026 |
95 | MP0009115_abnormal_fat_cell | 0.96814700 |
96 | MP0008873_increased_physiological_sensi | 0.96164339 |
97 | MP0004147_increased_porphyrin_level | 0.95148305 |
98 | MP0002971_abnormal_brown_adipose | 0.94325080 |
99 | MP0003638_abnormal_response/metabolism_ | 0.92779204 |
100 | MP0009764_decreased_sensitivity_to | 0.91050074 |
101 | MP0000358_abnormal_cell_content/ | 0.89255641 |
102 | MP0000350_abnormal_cell_proliferation | 0.88675682 |
103 | MP0001790_abnormal_immune_system | 0.87752424 |
104 | MP0005387_immune_system_phenotype | 0.87752424 |
105 | MP0002970_abnormal_white_adipose | 0.87111762 |
106 | MP0003075_altered_response_to | 0.87081749 |
107 | MP0008260_abnormal_autophagy | 0.84009667 |
108 | MP0008932_abnormal_embryonic_tissue | 0.82926512 |
109 | MP0005164_abnormal_response_to | 0.82308597 |
110 | MP0000003_abnormal_adipose_tissue | 0.80984331 |
111 | MP0005389_reproductive_system_phenotype | 0.79733524 |
112 | MP0009643_abnormal_urine_homeostasis | 0.78758528 |
113 | MP0009763_increased_sensitivity_to | 0.78354018 |
114 | MP0003300_gastrointestinal_ulcer | 0.76441576 |
115 | MP0008872_abnormal_physiological_respon | 0.75996761 |
116 | MP0000249_abnormal_blood_vessel | 0.75669610 |
117 | MP0004264_abnormal_extraembryonic_tissu | 0.75175141 |
118 | MP0008874_decreased_physiological_sensi | 0.75017440 |
119 | MP0004782_abnormal_surfactant_physiolog | 0.74743394 |
120 | MP0002877_abnormal_melanocyte_morpholog | 0.73486267 |
121 | MP0010329_abnormal_lipoprotein_level | 0.73437202 |
122 | MP0006082_CNS_inflammation | 0.71807945 |
123 | MP0003191_abnormal_cellular_cholesterol | 0.71424664 |
124 | MP0000371_diluted_coat_color | 0.71375068 |
125 | MP0008877_abnormal_DNA_methylation | 0.69284239 |
126 | MP0001905_abnormal_dopamine_level | 0.66829066 |
127 | MP0009278_abnormal_bone_marrow | 0.66775921 |
128 | MP0005266_abnormal_metabolism | 0.64302577 |
129 | MP0001730_embryonic_growth_arrest | 0.63485474 |
130 | MP0005376_homeostasis/metabolism_phenot | 0.61536713 |
131 | MP0005381_digestive/alimentary_phenotyp | 0.60503639 |
132 | MP0010352_gastrointestinal_tract_polyps | 0.60048918 |
133 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.58481406 |
134 | MP0002075_abnormal_coat/hair_pigmentati | 0.58461772 |
135 | MP0003448_altered_tumor_morphology | 0.57982525 |
136 | MP0000598_abnormal_liver_morphology | 0.57815415 |
137 | MP0005319_abnormal_enzyme/_coenzyme | 0.56161641 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Thrombocytosis (HP:0001894) | 8.11065163 |
2 | Reduced antithrombin III activity (HP:0001976) | 5.16897674 |
3 | Abnormal number of erythroid precursors (HP:0012131) | 4.92635427 |
4 | Abnormality of cells of the erythroid lineage (HP:0012130) | 4.81318572 |
5 | Type I transferrin isoform profile (HP:0003642) | 4.54775525 |
6 | Recurrent abscess formation (HP:0002722) | 4.44167291 |
7 | Reticulocytopenia (HP:0001896) | 4.39527699 |
8 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.39263603 |
9 | Recurrent bacterial skin infections (HP:0005406) | 4.17393127 |
10 | Aplastic anemia (HP:0001915) | 4.16826025 |
11 | Periodontitis (HP:0000704) | 3.95725739 |
12 | Myositis (HP:0100614) | 3.90909081 |
13 | Eczematoid dermatitis (HP:0000976) | 3.90155724 |
14 | Abnormal protein glycosylation (HP:0012346) | 3.64071849 |
15 | Abnormal glycosylation (HP:0012345) | 3.64071849 |
16 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 3.64071849 |
17 | Abnormal protein N-linked glycosylation (HP:0012347) | 3.64071849 |
18 | Agammaglobulinemia (HP:0004432) | 3.63501107 |
19 | IgM deficiency (HP:0002850) | 3.60319874 |
20 | Eosinophilia (HP:0001880) | 3.47760288 |
21 | Granulocytopenia (HP:0001913) | 3.44371917 |
22 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.36623010 |
23 | Petechiae (HP:0000967) | 3.27147706 |
24 | Papilledema (HP:0001085) | 3.16843593 |
25 | B lymphocytopenia (HP:0010976) | 3.03983709 |
26 | Abnormality of B cell number (HP:0010975) | 3.03983709 |
27 | Chronic otitis media (HP:0000389) | 3.02062776 |
28 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 2.99526067 |
29 | Hepatosplenomegaly (HP:0001433) | 2.97271942 |
30 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.96377410 |
31 | Abnormality of T cell physiology (HP:0011840) | 2.92354807 |
32 | Poikiloderma (HP:0001029) | 2.82510243 |
33 | Oral leukoplakia (HP:0002745) | 2.76549113 |
34 | Tubulointerstitial nephritis (HP:0001970) | 2.76139369 |
35 | Increased cerebral lipofuscin (HP:0011813) | 2.75668909 |
36 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.75460091 |
37 | Renal Fanconi syndrome (HP:0001994) | 2.74204770 |
38 | Recurrent skin infections (HP:0001581) | 2.70439877 |
39 | Progressive microcephaly (HP:0000253) | 2.67372806 |
40 | Hypergammaglobulinemia (HP:0010702) | 2.66952747 |
41 | Mediastinal lymphadenopathy (HP:0100721) | 2.66252946 |
42 | Abnormality of the thoracic spine (HP:0100711) | 2.62891048 |
43 | Neutropenia (HP:0001875) | 2.62756563 |
44 | Thoracic kyphosis (HP:0002942) | 2.60010650 |
45 | * Obstructive lung disease (HP:0006536) | 2.58366393 |
46 | * Chronic obstructive pulmonary disease (HP:0006510) | 2.58366393 |
47 | Amyloidosis (HP:0011034) | 2.54510543 |
48 | Duplicated collecting system (HP:0000081) | 2.53298975 |
49 | Abnormality of eosinophils (HP:0001879) | 2.52398535 |
50 | Rhabdomyolysis (HP:0003201) | 2.51622190 |
51 | Macrocytic anemia (HP:0001972) | 2.50799182 |
52 | * Meningitis (HP:0001287) | 2.49115050 |
53 | Impaired platelet aggregation (HP:0003540) | 2.44154866 |
54 | Abnormal platelet function (HP:0011869) | 2.44154866 |
55 | J-shaped sella turcica (HP:0002680) | 2.40448720 |
56 | Leukocytosis (HP:0001974) | 2.40294413 |
57 | Pancytopenia (HP:0001876) | 2.38761888 |
58 | Cutaneous photosensitivity (HP:0000992) | 2.37992742 |
59 | Prolonged bleeding time (HP:0003010) | 2.37186207 |
60 | Mitochondrial inheritance (HP:0001427) | 2.36763683 |
61 | Abnormality of macrophages (HP:0004311) | 2.36711729 |
62 | Hepatic necrosis (HP:0002605) | 2.34787208 |
63 | Pallor (HP:0000980) | 2.34381155 |
64 | Myelodysplasia (HP:0002863) | 2.32612611 |
65 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.32122686 |
66 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.31783095 |
67 | Recurrent cutaneous fungal infections (HP:0011370) | 2.31783095 |
68 | Severe visual impairment (HP:0001141) | 2.30435699 |
69 | Cellulitis (HP:0100658) | 2.27659207 |
70 | Recurrent fungal infections (HP:0002841) | 2.25662536 |
71 | Amaurosis fugax (HP:0100576) | 2.25314135 |
72 | Bone marrow hypocellularity (HP:0005528) | 2.23895821 |
73 | Agnosia (HP:0010524) | 2.23550629 |
74 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.22274276 |
75 | Recurrent viral infections (HP:0004429) | 2.21691510 |
76 | 11 pairs of ribs (HP:0000878) | 2.21310044 |
77 | Microvesicular hepatic steatosis (HP:0001414) | 2.21258089 |
78 | Abnormality of DNA repair (HP:0003254) | 2.20437869 |
79 | Acute myeloid leukemia (HP:0004808) | 2.20157827 |
80 | Panhypogammaglobulinemia (HP:0003139) | 2.17392905 |
81 | Generalized aminoaciduria (HP:0002909) | 2.17349406 |
82 | Loss of speech (HP:0002371) | 2.16765533 |
83 | * Skin rash (HP:0000988) | 2.14122969 |
84 | Entropion (HP:0000621) | 2.13157485 |
85 | Albinism (HP:0001022) | 2.13037044 |
86 | Abnormality of the renal collecting system (HP:0004742) | 2.12778624 |
87 | Chromsome breakage (HP:0040012) | 2.12601272 |
88 | Increased serum ferritin (HP:0003281) | 2.12455182 |
89 | Orchitis (HP:0100796) | 2.10752770 |
90 | Hepatocellular necrosis (HP:0001404) | 2.08905313 |
91 | Sepsis (HP:0100806) | 2.08714822 |
92 | Porencephaly (HP:0002132) | 2.07977806 |
93 | Cleft eyelid (HP:0000625) | 2.06787212 |
94 | Vacuolated lymphocytes (HP:0001922) | 2.06545123 |
95 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.03789235 |
96 | Exertional dyspnea (HP:0002875) | 2.03419465 |
97 | Birth length less than 3rd percentile (HP:0003561) | 2.03110699 |
98 | Increased CSF lactate (HP:0002490) | 2.02133690 |
99 | Ocular albinism (HP:0001107) | 2.01881078 |
100 | Increased hepatocellular lipid droplets (HP:0006565) | 2.01428484 |
101 | Poor head control (HP:0002421) | 2.01349779 |
102 | * Epistaxis (HP:0000421) | 1.98874761 |
103 | Visual hallucinations (HP:0002367) | 1.98143366 |
104 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.97186558 |
105 | Dicarboxylic aciduria (HP:0003215) | 1.97186558 |
106 | * Chest pain (HP:0100749) | 1.95802431 |
107 | Abnormality of iron homeostasis (HP:0011031) | 1.94748423 |
108 | Paralysis (HP:0003470) | 1.93860261 |
109 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.93058082 |
110 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.93058082 |
111 | Abnormality of glycolipid metabolism (HP:0010969) | 1.93058082 |
112 | Lipid accumulation in hepatocytes (HP:0006561) | 1.92352679 |
113 | Severe global developmental delay (HP:0011344) | 1.92143294 |
114 | Hypergonadotropic hypogonadism (HP:0000815) | 1.91089352 |
115 | Annular pancreas (HP:0001734) | 1.90320004 |
116 | Premature graying of hair (HP:0002216) | 1.89311285 |
117 | Abnormality of the lumbar spine (HP:0100712) | 1.87972766 |
118 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 1.87891444 |
119 | Ragged-red muscle fibers (HP:0003200) | 1.87875177 |
120 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.87850634 |
121 | Abnormality of lateral ventricle (HP:0030047) | 1.87825427 |
122 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 1.87192066 |
123 | Lymphoma (HP:0002665) | 1.86934514 |
124 | Hypertensive crisis (HP:0100735) | 1.86776537 |
125 | Abnormality of chromosome stability (HP:0003220) | 1.86131439 |
126 | Gingivitis (HP:0000230) | 1.86038597 |
127 | Osteomyelitis (HP:0002754) | 1.85694108 |
128 | Dysostosis multiplex (HP:0000943) | 1.85341124 |
129 | Increased intramyocellular lipid droplets (HP:0012240) | 1.83651203 |
130 | Degeneration of anterior horn cells (HP:0002398) | 1.83294835 |
131 | Abnormality of the anterior horn cell (HP:0006802) | 1.83294835 |
132 | Ureteral duplication (HP:0000073) | 1.83195448 |
133 | Gastrointestinal infarctions (HP:0005244) | 1.82775961 |
134 | Acute lymphatic leukemia (HP:0006721) | 1.82524663 |
135 | * Skin ulcer (HP:0200042) | 1.82416954 |
136 | Progressive muscle weakness (HP:0003323) | 1.81832152 |
137 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 1.81752223 |
138 | Lymphopenia (HP:0001888) | 1.81435006 |
139 | Spontaneous hematomas (HP:0007420) | 1.80692191 |
140 | Abnormality of pyrimidine metabolism (HP:0004353) | 1.80379460 |
141 | Abnormality of renal resorption (HP:0011038) | 1.80121259 |
142 | Increased muscle lipid content (HP:0009058) | 1.79324991 |
143 | Abnormality of T cells (HP:0002843) | 1.78530821 |
144 | Stomatitis (HP:0010280) | 1.78516332 |
145 | Respiratory difficulties (HP:0002880) | 1.78272755 |
146 | Abnormality of the columella (HP:0009929) | 1.78033478 |
147 | Microretrognathia (HP:0000308) | 1.77753745 |
Rank | Gene Set | Z-score |
---|---|---|
1 | VRK2 | 4.39570724 |
2 | EIF2AK3 | 4.35522056 |
3 | STK16 | 4.17602279 |
4 | IRAK4 | 3.35544672 |
5 | WEE1 | 2.77483756 |
6 | TEC | 2.49970258 |
7 | TNK2 | 2.39903701 |
8 | FES | 2.29660314 |
9 | MAP3K12 | 2.26484507 |
10 | PIM2 | 2.18768633 |
11 | CDC7 | 2.12338010 |
12 | BTK | 2.11374115 |
13 | NUAK1 | 2.08658368 |
14 | BUB1 | 2.07576558 |
15 | EEF2K | 2.07357060 |
16 | ARAF | 2.03282205 |
17 | TAOK3 | 2.01472023 |
18 | VRK1 | 2.01135820 |
19 | BLK | 1.92494433 |
20 | FLT3 | 1.90171992 |
21 | MAP4K1 | 1.88430420 |
22 | ERN1 | 1.81035592 |
23 | MAP4K2 | 1.80042057 |
24 | TESK2 | 1.75253046 |
25 | MAP2K3 | 1.71739377 |
26 | SMG1 | 1.68987341 |
27 | KIT | 1.67389261 |
28 | CAMKK2 | 1.63100931 |
29 | PKN2 | 1.61770388 |
30 | TNIK | 1.58114672 |
31 | CAMK1D | 1.51082957 |
32 | SCYL2 | 1.49868471 |
33 | EIF2AK1 | 1.45217954 |
34 | TAF1 | 1.43896612 |
35 | CDK12 | 1.42030645 |
36 | BRSK2 | 1.38526322 |
37 | CDK19 | 1.29283793 |
38 | RIPK4 | 1.26932165 |
39 | TESK1 | 1.25075826 |
40 | SYK | 1.24736629 |
41 | MKNK1 | 1.23482349 |
42 | NME2 | 1.22202787 |
43 | RPS6KB2 | 1.22176774 |
44 | CDK8 | 1.18845251 |
45 | ACVR1B | 1.18786810 |
46 | ATR | 1.15623938 |
47 | EIF2AK2 | 1.14323789 |
48 | SRPK1 | 1.14019838 |
49 | PAK4 | 1.12987195 |
50 | DAPK1 | 1.12406351 |
51 | CDK7 | 1.06702905 |
52 | NEK2 | 1.06543761 |
53 | TSSK6 | 1.02633436 |
54 | ZAP70 | 1.02560997 |
55 | MKNK2 | 1.02312309 |
56 | MAP3K6 | 0.97181684 |
57 | GRK7 | 0.96169255 |
58 | IRAK3 | 0.93803739 |
59 | KDR | 0.92132246 |
60 | MAPK4 | 0.91426431 |
61 | LRRK2 | 0.91262841 |
62 | ICK | 0.90594104 |
63 | GRK5 | 0.89693936 |
64 | TGFBR1 | 0.89188297 |
65 | MYLK | 0.87524248 |
66 | PIM1 | 0.84160649 |
67 | CLK1 | 0.84136098 |
68 | BCKDK | 0.83825684 |
69 | CSF1R | 0.83294907 |
70 | CDK4 | 0.81896448 |
71 | PASK | 0.81803457 |
72 | DYRK3 | 0.81040544 |
73 | ABL2 | 0.79339973 |
74 | LYN | 0.78976912 |
75 | GRK6 | 0.78569544 |
76 | BRAF | 0.78456185 |
77 | RPS6KL1 | 0.78219914 |
78 | RPS6KC1 | 0.78219914 |
79 | MAPKAPK3 | 0.78078045 |
80 | TYK2 | 0.77753494 |
81 | RPS6KA6 | 0.76484592 |
82 | MAP3K8 | 0.76251042 |
83 | AURKB | 0.74413549 |
84 | PLK4 | 0.74073043 |
85 | HIPK2 | 0.72604256 |
86 | RAF1 | 0.72008307 |
87 | CDK6 | 0.71179386 |
88 | MATK | 0.69506710 |
89 | CAMK1G | 0.68281275 |
90 | CCNB1 | 0.67834749 |
91 | ILK | 0.67365933 |
92 | CAMK1 | 0.67105208 |
93 | ITK | 0.66944714 |
94 | MAP3K7 | 0.66275289 |
95 | MOS | 0.64676212 |
96 | BRSK1 | 0.64399532 |
97 | MAP3K11 | 0.64159709 |
98 | PLK1 | 0.61592271 |
99 | RPS6KA2 | 0.57953052 |
100 | JAK3 | 0.56807772 |
101 | HCK | 0.56343965 |
102 | TRIM28 | 0.56077139 |
103 | CDK9 | 0.56054975 |
104 | LIMK1 | 0.55156384 |
105 | TRPM7 | 0.53062030 |
106 | LCK | 0.50684466 |
107 | TGFBR2 | 0.50490206 |
108 | PIK3CG | 0.48352342 |
109 | IKBKE | 0.47861615 |
110 | RPS6KB1 | 0.47608807 |
111 | RPS6KA5 | 0.47605511 |
112 | TXK | 0.45790566 |
113 | PAK1 | 0.44832237 |
114 | MAPKAPK5 | 0.44573385 |
115 | CHEK1 | 0.43714793 |
116 | RPS6KA4 | 0.43178348 |
117 | STK4 | 0.43014571 |
118 | TLK1 | 0.42592719 |
119 | MAP2K6 | 0.42555336 |
120 | CSNK2A2 | 0.41673951 |
121 | MAPK11 | 0.41236533 |
122 | CDK3 | 0.40875091 |
123 | DYRK2 | 0.40179438 |
124 | DAPK2 | 0.39649479 |
125 | PDK1 | 0.39492546 |
126 | IKBKB | 0.39130765 |
127 | TBK1 | 0.39127706 |
128 | CHEK2 | 0.38866140 |
129 | CAMKK1 | 0.38089458 |
130 | MARK2 | 0.37610872 |
131 | PDPK1 | 0.37588119 |
132 | CSNK2A1 | 0.37002009 |
133 | ADRBK1 | 0.35452187 |
134 | PAK2 | 0.33080122 |
135 | INSRR | 0.29185974 |
136 | AKT1 | 0.29162004 |
137 | PRKCQ | 0.28179600 |
138 | PRKCD | 0.26453145 |
139 | MAP2K2 | 0.25744616 |
Rank | Gene Set | Z-score |
---|---|---|
1 | DNA replication_Homo sapiens_hsa03030 | 5.33895137 |
2 | Ribosome_Homo sapiens_hsa03010 | 3.93294141 |
3 | Mismatch repair_Homo sapiens_hsa03430 | 3.44488139 |
4 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 3.06723836 |
5 | Base excision repair_Homo sapiens_hsa03410 | 2.95838570 |
6 | Protein export_Homo sapiens_hsa03060 | 2.94876826 |
7 | Homologous recombination_Homo sapiens_hsa03440 | 2.72862799 |
8 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 2.60983240 |
9 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 2.31640857 |
10 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.25456316 |
11 | Nucleotide excision repair_Homo sapiens_hsa03420 | 2.13075321 |
12 | Spliceosome_Homo sapiens_hsa03040 | 2.03878117 |
13 | Proteasome_Homo sapiens_hsa03050 | 2.02483491 |
14 | Renin-angiotensin system_Homo sapiens_hsa04614 | 2.00337778 |
15 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.87909492 |
16 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.85926009 |
17 | Other glycan degradation_Homo sapiens_hsa00511 | 1.79756898 |
18 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.72898623 |
19 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.68292803 |
20 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.66045856 |
21 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.64556985 |
22 | Leishmaniasis_Homo sapiens_hsa05140 | 1.52863981 |
23 | Cell cycle_Homo sapiens_hsa04110 | 1.52459588 |
24 | RNA polymerase_Homo sapiens_hsa03020 | 1.48812309 |
25 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.44029275 |
26 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.43007722 |
27 | RNA transport_Homo sapiens_hsa03013 | 1.42492767 |
28 | Galactose metabolism_Homo sapiens_hsa00052 | 1.38790952 |
29 | Huntingtons disease_Homo sapiens_hsa05016 | 1.36718335 |
30 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.35711295 |
31 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.30499787 |
32 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.28023461 |
33 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.27423168 |
34 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.24639533 |
35 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.23867395 |
36 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.20316606 |
37 | RNA degradation_Homo sapiens_hsa03018 | 1.20271208 |
38 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 1.14520780 |
39 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.14162608 |
40 | Alzheimers disease_Homo sapiens_hsa05010 | 1.06402244 |
41 | Purine metabolism_Homo sapiens_hsa00230 | 1.06154363 |
42 | Asthma_Homo sapiens_hsa05310 | 1.03660681 |
43 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.00960239 |
44 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.00185145 |
45 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.97702858 |
46 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.97665391 |
47 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.93083633 |
48 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.92406120 |
49 | Sulfur relay system_Homo sapiens_hsa04122 | 0.91269369 |
50 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.86477704 |
51 | Amoebiasis_Homo sapiens_hsa05146 | 0.86389129 |
52 | Legionellosis_Homo sapiens_hsa05134 | 0.85316877 |
53 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.85070691 |
54 | Peroxisome_Homo sapiens_hsa04146 | 0.83646226 |
55 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.82534058 |
56 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.81188140 |
57 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.81157439 |
58 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.81099687 |
59 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.80674731 |
60 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.79898662 |
61 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.79678779 |
62 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.79628154 |
63 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.76713415 |
64 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.74370329 |
65 | Phagosome_Homo sapiens_hsa04145 | 0.73135505 |
66 | Pertussis_Homo sapiens_hsa05133 | 0.72788815 |
67 | Carbon metabolism_Homo sapiens_hsa01200 | 0.72540488 |
68 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.72249970 |
69 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.71665329 |
70 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.67024451 |
71 | Lysosome_Homo sapiens_hsa04142 | 0.66980193 |
72 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.65812883 |
73 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.65359724 |
74 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.61770231 |
75 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.61096367 |
76 | Basal transcription factors_Homo sapiens_hsa03022 | 0.60243376 |
77 | Measles_Homo sapiens_hsa05162 | 0.59569619 |
78 | Thyroid cancer_Homo sapiens_hsa05216 | 0.59437079 |
79 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.58998549 |
80 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.58591927 |
81 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.58462991 |
82 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.57965275 |
83 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.57891883 |
84 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.56814379 |
85 | Malaria_Homo sapiens_hsa05144 | 0.55252465 |
86 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.54971846 |
87 | Apoptosis_Homo sapiens_hsa04210 | 0.54662859 |
88 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.53994592 |
89 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.53402135 |
90 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.53367677 |
91 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.53204698 |
92 | Shigellosis_Homo sapiens_hsa05131 | 0.52112610 |
93 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.52084589 |
94 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.50764008 |
95 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.49671936 |
96 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.49570570 |
97 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.47815093 |
98 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.45876218 |
99 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.45336354 |
100 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.44975804 |
101 | Tuberculosis_Homo sapiens_hsa05152 | 0.44920113 |
102 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.43806740 |
103 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.43566363 |
104 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.42247540 |
105 | Influenza A_Homo sapiens_hsa05164 | 0.41995995 |
106 | Hepatitis B_Homo sapiens_hsa05161 | 0.41341120 |
107 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.41319562 |
108 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.41147667 |
109 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.40337310 |
110 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.38929651 |
111 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.38362562 |
112 | Platelet activation_Homo sapiens_hsa04611 | 0.38267426 |
113 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.37889232 |
114 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.37637568 |
115 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.37550861 |
116 | Salmonella infection_Homo sapiens_hsa05132 | 0.37481868 |
117 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.36557335 |
118 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.35105610 |
119 | Metabolic pathways_Homo sapiens_hsa01100 | 0.34562960 |
120 | Allograft rejection_Homo sapiens_hsa05330 | 0.33632440 |
121 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.33586396 |
122 | Parkinsons disease_Homo sapiens_hsa05012 | 0.32774542 |
123 | Phototransduction_Homo sapiens_hsa04744 | 0.31868394 |
124 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.31498737 |
125 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.31458468 |
126 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.30858543 |
127 | Salivary secretion_Homo sapiens_hsa04970 | 0.30063339 |
128 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.29906999 |
129 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.29728640 |
130 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.29392992 |
131 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.27771473 |
132 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.27681389 |
133 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.26488788 |
134 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.25956301 |
135 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.25176118 |
136 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.23277709 |